Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024 ...Middle East

CARMIEL, Israel, Oct. 25, 2024 /PRNewswire/ -- Protalix BioTherapeutics, Inc. (NYSE American:PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell–based protein...

Hence then, the article about protalix biotherapeutics to present phase i prx 115 data in late breaking poster at acr convergence 2024 was published today ( Friday 25/10/2024 - 02:21 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024 )

Also on site :

• AI companies are building huge natural gas plants to power data centers. What could go wrong?
• The Trump Dictatorship Is Cracking Up
• Miami lands blue-chip quarterback for 2027 class